Skip to main content
. 2018 Jan 18;13(1):e0189832. doi: 10.1371/journal.pone.0189832

Table 6. Comparison between earlier RPD series and our study.

Study group: No of cases
(n)
Mean age at onset: (n± SD) Median age (Range): Symptom duration (median): M:F Most common etiology:
Papageorgiou et al.15
(Jan 2004-Dec 2006: RPD<1year)
68 65.5±10.0 66.7 (35.3–82.8) 6.7±3.06
(7)
37:31 1st: S-DEM: NPH
2nd: AD
3rd: FTD
Sala et al.16(Oct 1994-Mar 2009: RPD<1 year) 49 72.4±11.6 NA 4.6±3.8 22:27 1st ND: AD
2nd: Prion disease
3rd: vascular and toxic/metabolic
Studart Neto et al17
(Mar 2012-Feb 2015: RPD<2years)
61 48±19.6 (14–84) 6.4±6.6 22:39 1st: immune mediated
2nd:infectious disorders
3rd: Prion diseases
Our study: (Jan 2008-Aug 2016: RPD<1 year) 187 49.3±18.2 50 (13–84) 5.28±4.1
(4)
122:65 1st: immune mediated
2nd: infectious disorders
3rd: non-prion neurodegenerative: FTD

SD: standard deviation, F: females, M: males, S-DEM: secondary dementia, NPH: normal pressure hydrocephalus, AD: Alzheimer’s disease, FTD: frontotemporal dementia, ND: neurodegenerative dementias.